- Home
- ZGN vs BHC Comparison
ZGN vs BHC Comparison
Compare ZGN & BHC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZGN
- BHC
- Stock Information
- Founded
- ZGN 1910
- BHC N/A
- Country
- ZGN Italy
- BHC Canada
- Employees
- ZGN N/A
- BHC N/A
- Industry
- ZGN Apparel
- BHC Biotechnology: Pharmaceutical Preparations
- Sector
- ZGN Consumer Discretionary
- BHC Health Care
- Exchange
- ZGN Nasdaq
- BHC Nasdaq
- Market Cap
- ZGN 2.0B
- BHC 2.3B
- IPO Year
- ZGN N/A
- BHC N/A
- Fundamental
- Price
- ZGN $9.15
- BHC $7.08
- Analyst Decision
- ZGN Buy
- BHC Hold
- Analyst Count
- ZGN 2
- BHC 5
- Target Price
- ZGN $8.05
- BHC $7.20
- AVG Volume (30 Days)
- ZGN 1.9M
- BHC 3.1M
- Earning Date
- ZGN 03-27-2025
- BHC 07-30-2025
- Dividend Yield
- ZGN 1.54%
- BHC N/A
- EPS Growth
- ZGN N/A
- BHC N/A
- EPS
- ZGN 0.31
- BHC N/A
- Revenue
- ZGN $2,015,371,157.00
- BHC $9,731,000,000.00
- Revenue This Year
- ZGN $0.74
- BHC $3.71
- Revenue Next Year
- ZGN $4.74
- BHC $5.03
- P/E Ratio
- ZGN $29.46
- BHC N/A
- Revenue Growth
- ZGN 2.21
- BHC 8.53
- 52 Week Low
- ZGN $6.05
- BHC $3.96
- 52 Week High
- ZGN $11.69
- BHC $9.85
- Technical
- Relative Strength Index (RSI)
- ZGN 63.83
- BHC 80.44
- Support Level
- ZGN $8.24
- BHC $6.38
- Resistance Level
- ZGN $8.99
- BHC $7.24
- Average True Range (ATR)
- ZGN 0.32
- BHC 0.33
- MACD
- ZGN -0.01
- BHC 0.11
- Stochastic Oscillator
- ZGN 86.32
- BHC 89.29
About ZGN Ermenegildo Zegna N.V.
Ermenegildo Zegna NV designs creates, and distributes luxury menswear and accessories under the Zegna brand, as well as womenswear, menswear, and accessories under the Thom Browne brand. The company operates in three segments: the Zegna segment (comprising three product lines: Zegna Branded Products, Textile, and Third Party Brands); the Thom Browne segment, and the Tom Ford Fashion segment. The company generates the majority of its revenue from the Zegna segment.
About BHC Bausch Health Companies Inc.
Bausch Health Companies Inc is a world-wide specialty pharmaceutical, consumer health, and medical device company with a focus on branded products for the gastroenterology, hepatology, neurology and dermatology markets. The company reports revenue in five segments: Salix; International; Solta Medical; Diversified Products and Bausch + Lomb. It generates maximum revenue from the Bausch + Lomb segment.